Stage 2 Core Measure 6
Objective: Use clinical decision support to improve performance on high priority health conditions.
- Implement five clinical decision support interventions related to four or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period. Absent four clinical quality measures related to an EP's scope of practice or patient population, the clinical decision support interventions must be related to high-priority health conditions; and
- The EP has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period.
CMS Specification Sheet
- An EP who writes fewer than 100 medication orders during the EHR reporting period.
This objective and measure greatly expands upon the single clinical decision support (CDS) rule in Core Measure 11 in Stage 1 as well as combining with Stage 1's Core Measure 2 regarding drug-drug and drug-allergy interaction checks. Unlike in Stage 1, the CDS interventions cannot stand alone, but must relate to clinical quality measures if four are applicable to the EP's scope of practice. Note that the exclusion applies only to part B of the measure; there is no exclusion for part A.
Federal Regulations Governing This Measure
CMS' Final Rule
§ 495.6(j)(6)(ii) see objective, measure and exclusion above
Standards and Certification Final Rule
§ 170.314(a)(8) Clinical decision support
(i) Evidence-based decision support interventions. Enable a limited set of identified users to select (i.e., activate) one or more electronic clinical decision support interventions (in addition to drug-drug and drug-allergy contraindication checking) based on each one and at least one combination of the following data:
(A) Problem list;
(B) Medication list;
(C) Medication allergy list;
(E) Laboratory tests and values/results; and
(F) Vital signs.